Literature DB >> 21710479

PLP-dependent enzymes as entry and exit gates of sphingolipid metabolism.

Florence Bourquin1, Guido Capitani, Markus Gerhard Grütter.   

Abstract

Sphingolipids are membrane constituents as well as signaling molecules involved in many essential cellular processes. Serine palmitoyltransferase (SPT) and sphingosine-1-phosphate lyase (SPL), both PLP (pyridoxal 5'-phosphate)-dependent enzymes, function as entry and exit gates of the sphingolipid metabolism. SPT catalyzes the condensation of serine and a fatty acid into 3-keto-dihydrosphingosine, whereas SPL degrades sphingosine-1-phosphate (S1P) into phosphoethanolamine and a long-chain aldehyde. The recently solved X-ray structures of prokaryotic homologs of SPT and SPL combined with functional studies provide insight into the structure-function relationship of the two enzymes. Despite carrying out different reactions, the two enzymes reveal striking similarities in the overall fold, topology, and residues crucial for activity. Unlike their eukaryotic counterparts, bacterial SPT and SPL lack a transmembrane helix, making them targets of choice for biochemical characterization because the use of detergents can be avoided. Both human enzymes are linked to severe diseases or disorders and might therefore serve as targets for the development of therapeutics aiming at the modulation of their activity. This review gives an overview of the sphingolipid metabolism and of the available biochemical studies of prokaryotic SPT and SPL, and discusses the major similarities and differences to the corresponding eukaryotic enzymes.
Copyright © 2011 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710479      PMCID: PMC3190145          DOI: 10.1002/pro.679

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  139 in total

Review 1.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

2.  Products by the sphingosine kinase/sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis.

Authors:  Yuki Kariya; Akio Kihara; Mika Ikeda; Fumiaki Kikuchi; Seiichi Nakamura; Shunichi Hashimoto; Chang-Hwan Choi; Yong-Moon Lee; Yasuyuki Igarashi
Journal:  Genes Cells       Date:  2005-06       Impact factor: 1.891

Review 3.  Glycosphingolipids and drug resistance.

Authors:  Valerie Gouaze-Andersson; Myles C Cabot
Journal:  Biochim Biophys Acta       Date:  2006-08-26

4.  Structural basis of the sphingomyelin phosphodiesterase activity in neutral sphingomyelinase from Bacillus cereus.

Authors:  Hideo Ago; Masataka Oda; Masaya Takahashi; Hideaki Tsuge; Sadayuki Ochi; Nobuhiko Katunuma; Masashi Miyano; Jun Sakurai
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

5.  The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.

Authors:  Steven W Paugh; Shawn G Payne; Suzanne E Barbour; Sheldon Milstien; Sarah Spiegel
Journal:  FEBS Lett       Date:  2003-11-06       Impact factor: 4.124

6.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers.

Authors:  Kathleen Hibbs; Keith M Skubitz; Stefan E Pambuccian; Rachael C Casey; Kathryn M Burleson; Theodore R Oegema; Jeannine J Thiele; Suzanne M Grindle; Robin L Bliss; Amy P N Skubitz
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

7.  Multifunctional role of His159in the catalytic reaction of serine palmitoyltransferase.

Authors:  Yuka Shiraiwa; Hiroko Ikushiro; Hideyuki Hayashi
Journal:  J Biol Chem       Date:  2009-04-05       Impact factor: 5.157

8.  ABC transporters in cancer: more than just drug efflux pumps.

Authors:  Jamie I Fletcher; Michelle Haber; Michelle J Henderson; Murray D Norris
Journal:  Nat Rev Cancer       Date:  2010-01-15       Impact factor: 60.716

Review 9.  Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function.

Authors:  Montserrat Serra; Julie D Saba
Journal:  Adv Enzyme Regul       Date:  2009-11-13

10.  Sphingosine-1-phosphate synthesis and functions in mast cells.

Authors:  Megan M Price; Carole A Oskeritzian; Sheldon Milstien; Sarah Spiegel
Journal:  Future Lipidol       Date:  2008-12-01
View more
  20 in total

Review 1.  Truth and consequences of sphingosine-1-phosphate lyase.

Authors:  Ana Aguilar; Julie D Saba
Journal:  Adv Biol Regul       Date:  2012-01

Review 2.  Orm/ORMDL proteins: Gate guardians and master regulators.

Authors:  Deanna Davis; Muthukumar Kannan; Binks Wattenberg
Journal:  Adv Biol Regul       Date:  2018-08-31

3.  Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire.

Authors:  Jung H Suh; Julie D Saba
Journal:  Transl Cancer Res       Date:  2015-10-01       Impact factor: 1.241

4.  Semi-rational approach to expand the Acyl-CoA Chain length tolerance of Sphingomonas paucimobilis serine palmitoyltransferase.

Authors:  Hyunjun Choe; Minsun Cha; Jon D Stewart
Journal:  Enzyme Microb Technol       Date:  2020-01-21       Impact factor: 3.493

Review 5.  S1P lyase in skeletal muscle regeneration and satellite cell activation: exposing the hidden lyase.

Authors:  Julie D Saba; Anabel S de la Garza-Rodea
Journal:  Biochim Biophys Acta       Date:  2012-06-28

Review 6.  Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism.

Authors:  Youn-Jeong Choi; Julie D Saba
Journal:  Adv Biol Regul       Date:  2018-09-25

7.  Vitamin B-6 restriction impairs fatty acid synthesis in cultured human hepatoma (HepG2) cells.

Authors:  Mei Zhao; Maria A Ralat; Vanessa da Silva; Timothy J Garrett; Stephan Melnyk; S Jill James; Jesse F Gregory
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-04       Impact factor: 4.310

Review 8.  Novel chemotherapeutic drugs in sphingolipid cancer research.

Authors:  Daniel Canals; Yusuf A Hannun
Journal:  Handb Exp Pharmacol       Date:  2013

9.  Identification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis.

Authors:  Thomas Cruz; Marie Gleizes; Stéphane Balayssac; Etienne Mornet; Grégory Marsal; José Luis Millán; Myriam Malet-Martino; Lionel G Nowak; Véronique Gilard; Caroline Fonta
Journal:  J Neurochem       Date:  2017-03       Impact factor: 5.372

Review 10.  Genotype/Phenotype Interactions and First Steps Toward Targeted Therapy for Sphingosine Phosphate Lyase Insufficiency Syndrome.

Authors:  Julie D Saba; Nancy Keller; Jen-Yeu Wang; Felicia Tang; Avi Slavin; Yizhuo Shen
Journal:  Cell Biochem Biophys       Date:  2021-06-16       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.